CAS 105816-04-4
:Nateglinid
- AY 4166
- N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
- D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-
- D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, trans-
- A 4166
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Nateglinide
CAS:Formel:C19H27NO3Reinheit:>98.0%(HPLC)(T)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:317.43NATEGLINIDE CRS
CAS:NATEGLINIDE CRSFormel:C19H27NO3Farbe und Form:White. Powder.Molekulargewicht:317.4226Nateglinide
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof, nesoiFormel:C19H27NO3Farbe und Form:White PowderMolekulargewicht:317.19909Nateglinide
CAS:Formel:C19H27NO3Reinheit:≥ 98.0%Farbe und Form:White to off-white powderMolekulargewicht:317.42Nateglinide (Standard)
CAS:Nateglinide (Standard) is a reference standard of Nateglinide intended for quantitative analysis, quality control, and related biochemical research applications.Formel:C19H27NO3Molekulargewicht:317.4226Nateglinide
CAS:Kontrolliertes ProduktApplications An amino-acid derivative that stimulates insulin secretion. Used as an antidiabetic.
References Shinkai, H., et al.: J. Med. Chem., 32, 1436 (1989), Sato, Y., et al.: Diabetes Res. Clin. Pract., 12, 53 (1991), Vicent, D., et al.: J. Clin. Invest., 111, 1373 (2003), Ceriello, A., et al.: Diabet. Med., 21, 171 (2004),Formel:C19H27NO3Farbe und Form:NeatMolekulargewicht:317.42Nateglinide
CAS:(R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoic acidFormel:C19H27NO3Reinheit:99%Molekulargewicht:317.42Nateglinide
CAS:Nateglinide is an oral drug for type 2 diabetes, stimulating insulin release; may cause rare acute liver injury.Formel:C19H27NO3Reinheit:99.93% - 99.94%Farbe und Form:SolidMolekulargewicht:317.4226Nateglinide - Bio-X ™
CAS:Nateglinide is used to treat type 2 diabetes mellitus as an oral hypoglycemic, insulinotropic agent. It is a blocker of ATP-dependent potassium channels and works by increasing the body's production of insulin, which lowers blood glucose levels. Nateglinide has been shown to be effective in reducing postprandial blood glucose levels in patients with type 2 diabetes who have not responded well to other treatments. The effects of nateglinide are reversible.Formel:C19H27NO3Reinheit:Min. 95%Molekulargewicht:317.42 g/molNateglinide
CAS:Nateglinide is used to treat type 2 diabetes mellitus as an oral hypoglycemic, insulinotropic agent. It is a blocker of ATP-dependent potassium channels and works by increasing the body's production of insulin, which lowers blood glucose levels. Nateglinide has been shown to be effective in reducing postprandial blood glucose levels in patients with type 2 diabetes who have not responded well to other treatments. The effects of nateglinide are reversible.
Formel:C19H27NO3Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:317.42 g/mol















